{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:51:49Z","timestamp":1781801509865,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment with NovaSure\u00ae endometrial ablation is approved for patients with heavy menstrual bleeding (HMB) without evidence of malignant or premalignant lesions. This analysis addresses the rare but clinically relevant situation in which endometrial carcinoma (EC) or atypical hyperplasia (AEH) is identified histologically after endometrial ablation in premenopausal patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Histological evaluation of hysterectomy specimens with correlation to clinical parameters in patients undergoing hysterectomy after incidental histological diagnosis of AEH or EC following NovaSure\u00ae endometrial ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective single-center analysis was conducted on more than 400 patients who underwent NovaSure\u00ae endometrial ablation at our center between January 2020 and February 2025. Patients with AEH or EC for whom subsequent hysterectomy specimens were available were included. Histological evaluation was performed and independently reviewed to assess residual endometrium, residual endometrial atypia or carcinoma, and ablation-related histomorphological changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 11 patients (AEH\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098; EC\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) underwent subsequent hysterectomy after NovaSure\u00ae endometrial ablation. Six out of eight patients with AEH showed no residual atypia in the hysterectomy specimens (2\/8 with focal residual atypia), and no residual invasive carcinoma was detected in any of the three carcinoma cases. Histopathological analysis showed pronounced postablative changes, including necrosis, fibrosis, zonation, and vascular and lymphatic alterations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This descriptive study provides a clinicopathological characterization of patients with EC or AEH who underwent hysterectomy after endometrial ablation. In these patients, no preprocedural evidence of endometrial pathology was present, and the diagnosis was established solely through routine histopathological examination of curettage specimens obtained immediately before the ablation procedure. Histological assessment revealed pronounced changes, highlighting specific diagnostic challenges and underscoring the importance of careful patient selection and thorough diagnostic evaluation before NovaSure\u00ae ablation. Within the limitations of this study, no evidence was found that prior endometrial ablation compromises oncological outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-026-08497-x","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:27:53Z","timestamp":1781796473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histological evaluation of hysterectomy specimens after NovaSure\u00ae endometrial ablation in patients with atypical endometrial hyperplasia or endometrial carcinoma"],"prefix":"10.1007","volume":"313","author":[{"given":"Oliver M.","family":"Schleicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Hamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Poeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik A.","family":"Stuebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Burghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Matek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Emons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"1","key":"8497_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ajog.2015.07.044","volume":"214","author":"LD Bradley","year":"2016","unstructured":"Bradley LD, Gueye NA (2016) The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol 214(1):31\u201344","journal-title":"Am J Obstet Gynecol"},{"issue":"05","key":"8497_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/a-1933-9598","volume":"18","author":"M H\u00f6rner","year":"2024","unstructured":"H\u00f6rner M, Bader S, Au K, Hofbeck L, Windischbauer L-M, Burghaus S et al (2024) Abnorme uterine Blutungen. Frauenheilkunde up2date. 18(05):393\u2013408","journal-title":"Frauenheilkunde up2date."},{"issue":"3","key":"8497_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1074-3804(05)60405-7","volume":"9","author":"A Gallinat","year":"2002","unstructured":"Gallinat A, Nugent W (2002) NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc 9(3):283\u2013289","journal-title":"J Am Assoc Gynecol Laparosc"},{"issue":"8","key":"8497_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152992","volume":"216","author":"G Karpathiou","year":"2020","unstructured":"Karpathiou G, Chauleur C, Dal Col P, Dridi M, Laville D, Mobarki M et al (2020) Histologic findings in hysterectomies after endometrial ablation. Pathol Res Pract 216(8):152992","journal-title":"Pathol Res Pract"},{"issue":"9","key":"8497_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.5858\/2005-129-1175-POTNRI","volume":"129","author":"O Fadare","year":"2005","unstructured":"Fadare O, Qin L, Martel M, Tavassoli FA (2005) Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system. Arch Pathol Lab Med 129(9):1175\u20131178","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"8497_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1471-0528.14385","volume":"124","author":"M Pennant","year":"2017","unstructured":"Pennant M, Mehta R, Moody P, Hackett G, Prentice A, Sharp S et al (2017) Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG: Int J Obstet Gynaecol 124(3):404\u2013411","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"12","key":"8497_CR7","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.21037\/tcr.2020.04.20","volume":"9","author":"MM Terzic","year":"2020","unstructured":"Terzic MM, Aimagambetova G, Terzic S, Norton M, Bapayeva G, Garzon S (2020) Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer. Transl Cancer Res 9(12):7716\u20137724","journal-title":"Transl Cancer Res"},{"issue":"1","key":"8497_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejogrb.2010.02.002","volume":"150","author":"H-S Hahn","year":"2010","unstructured":"Hahn H-S, Chun Y-K, Kwon Y-I, Kim T-J, Lee K-H, Shim J-U et al (2010) Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 150(1):80\u201383","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"8497_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/AOG.0b013e3181b190d5","volume":"114","author":"E Suh-Burgmann","year":"2009","unstructured":"Suh-Burgmann E, Hung YY, Armstrong MA (2009) Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage. Obstet Gynecol 114(3):523\u2013529","journal-title":"Obstet Gynecol"},{"issue":"4","key":"8497_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cncr.21650","volume":"106","author":"CL Trimble","year":"2006","unstructured":"Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2nd et al (2006) Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 106(4):812\u2013819","journal-title":"Cancer"},{"issue":"11","key":"8497_CR11","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/PAS.0b013e31825dd4ff","volume":"36","author":"E Rakha","year":"2012","unstructured":"Rakha E, Wong SC, Soomro I, Chaudry Z, Sharma A, Deen S et al (2012) Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature. Am J Surg Pathol 36(11):1683\u20131690","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"8497_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1055\/a-2293-5700","volume":"84","author":"P P\u00f6schke","year":"2024","unstructured":"P\u00f6schke P, Gass P, Kr\u00fcckel A, Keller K, Erber R, Hartmann A et al (2024) Clinical and surgical evaluation of sentinel node biopsy in patients with early-stage endometrial cancer and atypical hyperplasia. Geburtshilfe Frauenheilkd 84(5):470\u2013476","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"8497_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1620\/tjem.228.365","volume":"228","author":"H Kurosawa","year":"2012","unstructured":"Kurosawa H, Ito K, Nikura H, Takano T, Nagase S, Utsunomiya H et al (2012) Hysteroscopic inspection and total curettage are insufficient for discriminating endometrial cancer from atypical endometrial hyperplasia. Tohoku J Exp Med 228(4):365\u2013370","journal-title":"Tohoku J Exp Med"},{"key":"8497_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejogrb.2018.02.017","volume":"223","author":"LHP Parsons","year":"2018","unstructured":"Parsons LHP, Pedersen R, Richardson DL, Kho KA (2018) The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications. Eur J Obstet Gynecol Reprod Biol 223:108\u2013112","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"8497_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejogrb.2009.06.014","volume":"147","author":"SJ Ahonkallio","year":"2009","unstructured":"Ahonkallio SJ, Liakka AK, Martikainen HK, Santala MJ (2009) Feasibility of endometrial assessment after thermal ablation. Eur J Obstet Gynecol Reprod Biol 147(1):69\u201371","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"8497_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","volume":"18","author":"EC Rossi","year":"2017","unstructured":"Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18(3):384\u2013392","journal-title":"Lancet Oncol"},{"issue":"2","key":"8497_CR17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ygyno.2017.02.018","volume":"145","author":"B Geppert","year":"2017","unstructured":"Geppert B, L\u00f6nnerfors C, Bollino M, Arechvo A, Persson J (2017) A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol 145(2):256\u2013261","journal-title":"Gynecol Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08497-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:55:04Z","timestamp":1781798104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8497"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08497-x","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the Ethics Committee of Friedrich-Alexander University Erlangen-N\u00fcrnberg (Approval No. 24-41-Br, Date: 04.03.2024). Due to the study\u2019s retrospective nature, informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participant consent was unnecessary due to the study\u2019s retrospective design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"207"}}